Department of the Army 2008 – Federal Register Recent Federal Regulation Documents

The Department of the Army is amending a system of records notice in its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

The Department of the Army is amending a system of records notice in its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

The Department of the Army announces the availability of the Final SPEIS for the growth and realignment of the U.S. Army to support operations in the Pacific Theater. Pursuant to the National Environmental Policy Act (NEPA), the Department of the Army has prepared a Final SPEIS that evaluates the potential environmental and socioeconomic effects associated with alternatives for implementing the growth and realignment of the Army's forces to support operations in the Pacific Theater. Potential impacts have been analyzed in the Final SPEIS at installations that are capable of supporting operations in the Pacific Theater.

The Department of the Army is proposing to alter a system of records in its existing inventory of records systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

The Department of the Army is deleting a system of records notice in its existing inventory of record systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

Section 302 of Public Law 99-662 established the Inland Waterways Users Board. The Board is an independent Federal advisory committee. The Secretary of the Army appoints its 11 members. This notice is to solicit nominations for six (6) appointments or reappointments to two-year terms that will begin after March 1, 2009.

The Department of the Army is amending a system of records notice in its existing inventory of record systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Sunshine in the Government Act of 1976 (U.S.C. 552b, as amended) and 41 Code of the Federal Regulations (CFR 102-3. 140 through 160), the Department of the Army announces the following committee meeting: Name of Committee: Army Science Board (ASB). Date(s) of Summer Study Meeting: July 14-24, 2008. Time(s) of Meeting: 0800-1700, July 14, 2008. 0800-1500, July 23, 2008. Place of Meeting: Arnold and Mabel Beckman Center, 100 Academy Drive, Irvine, CA 92617.

In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent No. 6,451,309 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 17, 2002; and U.S. Patent No. 6,620,412 entitled, ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 16, 2003, which is a continuation of U.S. Patent No. 6,451,309. Foreign rights are also available (PCT/US01/04520). The United States Government, as represented by the Secretary of the Army, has rights in this invention.

In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 11/464,001 entitled ``Broad Spectrum Antibacterial Compounds,'' filed August 11, 2006. Foreign rights are also available (PCT/US06/031550). The United States Government, as represented by the Secretary of the Army, has rights in this invention.

The Department of the Army is proposing to alter a system of records in its existing inventory of records systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

The Department of the Army is proposing to amend a system of records notice in its existing inventory of records systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

In accordance with 37 CFR part 404.6, announcement is made of the availability for licensing of U.S. Patent No. U.S. 7,380,548 entitled ``Stove Apparatus'' issued June 3, 2008. This patent has been assigned to the United States Government as represented by the Secretary of the Army.

Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Sunshine in the Government Act of 1976 (U.S.C. 552b, as amended) and 41 Code of the Federal Regulations (CFR 102-3.140 through 160), the Department of the Army announces the following committee meeting: Name of Committee: Army Education Advisory Committee. Date: July 7, 2008. Place: Meeting will be conducted electronically online using Adobe Connect. Time: 1400-1500.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), announcement is made of the following committee meeting:

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. U.S. 7,344,751 entitled ``Article of Footwear with Temperature Regulation Means'' issued April 29, 2008. This patent has been assigned to the United States Government as represented by the Secretary of the Army.

As part of the GTA effort, the U. S. Army intends to prepare an EIS to analyze the environmental and socioeconomic impacts resulting from the decision to station a new Infantry Brigade Combat Team (IBCT) at Fort Carson. The EIS will also analyze Fort Carson's Butts Army Airfield (BAAF) as a potential location for stationing a Combat Aviation Brigade (CAB) in the future.

Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, the Department of Defense announces that the following Federal advisory committee meeting will take place: 1. Name of Committee: United States Military Academy Board of Visitors. 2. Date: Wednesday, May 14, 2008. 3. Time: 1 p.m.-4 p.m. Members of the public wishing to attend the meeting will need to show photo identification in order to gain access to the meeting location. All participants are subject to security screening. 4. Location: Senate Russell Office Building, Washington, DC 20515 (exact room location will be published on the USMA Board of Visitors Web site at https://www.usma.edu/bov.asp). 5. Purpose of the Meeting: This is the 2008 Spring Meeting of the USMA Board of Visitors (BoV). Members of the Board will be provided updates on Academy issues. 6. Agenda: The Academy leadership will provide the Board updates on the following: Admissions, The Center of Professional Military Ethics, Capstone Course, FY08 & FY09 Budget and Manpower, Business Transformation, USMA Master Plan, Uniform Code of Military Justice (UCMJ), Accreditation, Residential Communities Initiative (RCI), and Diversity. 7. Public's Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b and 41 CFR 102-3.140 through 102-3.165, and the availability of space, this meeting is open to the public. Seating is on a first-come basis. 8. Committee's Designated Federal Officer or Point of Contact: Ms. Cynthia Kramer, (845) 938-5078, Cynthia.kramer@us.army.mil.

Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Sunshine in the Government Act of 1976 (U.S.C. 552b, as amended) and 41 Code of the Federal Regulations (CFR 102-3. 140 through 160, the Department of the Army announces the following committee meeting: Name of Committee: Army Science Board (ASB). Date(s) of Meeting: May 20-21, 2008. Time(s) of Meeting: 0800-1700, May 20, 2008-1300-1600, May 21, 2008. Place of Meeting: Minute Maid Park, 6580 Fannin Street, Houston, TX.

This action removes 32 CFR Part 502, Relief Assistance. The regulations are being removed because they are obsolete and no longer govern policies and procedures for disaster relief activities. The program responsibility has been transferred to the Office of the Assistant Secretary of Defense for Homeland Defense.

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. U.S. 7,347,768 entitled ``Apparatus and Method to Test Abrasion Resistance of Material Using Airborne Particulate'' issued March 25, 2008. This patent has been assigned to the United States Government as represented by the Secretary of the Army.

In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. Patent 6,825,323, filed January 10, 2001, entitled ``Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using the same'' and foreign rights (PCT/US01/000725) to ProFibrix B.V., with its principal place of business at Zernikedreef 9, 2333 CK Leiden, The Netherlands.